Overview

Oxygen Therapy for Retinal Ischemia

Status:
Withdrawn
Trial end date:
2020-01-01
Target enrollment:
0
Participant gender:
All
Summary
The investigators will be using nocturnal normobaric hyperoxia therapy in patients with diagnoses of conditions related to retinal ischemia.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Criteria
Inclusion Criteria:

- Diagnosis of retinal-ischemia related condition

Exclusion Criteria:

- Complicating other ocular condition

- History of smoking or lung conditions